Stocktoria

DNA X, Inc. SONM

Nasdaq · stock · Telephone & Telegraph Apparatus · website · IPO 2019-05-10

DNA X, Inc. financials (annual)

Revenue
$135.7M $116.3M $64.0M $54.6M $69.8M $93.6M $58.3M 20182019202020212022202320242025
Net income
$1.3M -$25.8M -$29.9M -$38.6M -$14.1M -$90000 -$33.6M -$20.7M 20182019202020212022202320242025
Free cash flow
$3.1M -$34.5M -$10.6M -$38.5M -$12.4M -$4.1M -$8.7M 20182019202020212022202320242025

Bars are annual figures from 2018 to 2025; red bars are negative (a loss or cash outflow).

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Revenue$58.3M$93.6M$69.8M$54.6M$64.0M$116.3M$135.7M
Gross profit$9.9M$19.3M$11.6M$6.4M$15.2M$34.5M$48.1M
R&D expense$14.2M$1.8M$8.0M$17.7M$16.2M$26.1M$23.2M
Operating income-$5.4M-$3.1M$513,000-$14.3M-$38.0M-$29.3M-$22.4M$5.4M
Interest expense$945,000$97,000
Income tax-$1.1M$226,000$374,000$184,000$167,000-$521,000$1.4M$754,000
Net income-$20.7M-$33.6M-$90,000-$14.1M-$38.6M-$29.9M-$25.8M$1.3M
EPS (diluted)$-28.58$-128.37$-0.02$-0.49
Operating cash flow-$23.5M-$8.5M-$4.1M-$12.4M-$38.5M-$10.6M-$33.5M$3.9M
Free cash flow-$8.7M-$4.1M-$12.4M-$38.5M-$10.6M-$34.5M$3.1M
Cash & equivalents$1.3M$5.3M$9.4M$13.2M$11.2M$22.1M$11.3M$13.0M
Inventory$10.6M$6.5M$3.9M$5.5M$11.3M$19.5M$21.8M
Total assets$43.9M$39.7M$56.0M$53.7M$41.1M$50.3M$55.5M$67.3M
Total liabilities$50.6M$45.4M$33.7M$33.6M$22.5M$21.9M$29.9M$62.2M
Shareholders' equity-$8.0M-$5.7M$22.4M$20.0M$18.6M$28.4M$25.5M$5.1M

Growth · year-over-year · Revenue CAGR -13.1%

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Revenue growth-37.7%+34.1%+28.0%-14.7%-45.0%-14.3%
Net income growth-2123.0%
Free cash flow growth-1222.8%

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.